Mr. Andre Godin reports

BIOFLEX TECHNOLOGIES INC. ANNOUNCES APPOINTMENT OF DIRECTOR AND NEW CEO AND STOCK OPTION GRANT

Bioflex Technologies Inc. has appointed Michel Timperio to the board of directors.

Andre Godin, chairman, stated: "We are very pleased to welcome Michel to the board of Bioflex Technologies. Michel brings a wealth of experience in sales, marketing and business and strategic development which will greatly benefit the company." Mr. Godin added, "We believe that we now have a well-rounded team at the board level with the combined experience to provide the right challenge and strategic direction to our management team."

The company would like to thank the outgoing directors, Wayne Cockburn and Michael Newman, for their contributions to the company.

Mr. Timperio currently holds the position of vice-president of global sales at Neptune Technologies & Bioressources Inc. He has been employed by Neptune since 2010, but was a member of the board of directors from 2000 to 2008. Mr. Timperio has many years of experience in sales. He obtained his BComm at Concordia University in Montreal, Que. With a natural entrepreneurial character, he launched his own distributing business. Many years later, Mr. Timperio built a start-up venture in residential construction from 2001 to 2010. He has worked for large corporations, including Armstrong World Industries and Reichhold Chemicals, where he held senior management business development positions. Mr. Timperio also had a political career from 1982 to 2000 in Longueuil, a large suburb of Montreal, where he was part of the leading council for many years.

The company also announced strategic changes to the management team with the appointment of Leena Lakdawala as chief executive officer of the company. Mr. Godin stated: "The board of directors is indeed very pleased with the appointment of Leena as chief executive officer. Leena brings extensive executive management experience in public and private companies and we believe she has the right profile to provide the right strategic direction to Bioflex and ensure the execution of the company's business plan." The company is pleased that its outgoing chief executive officer, Mr. Cockburn, will continue to assist the company in its business development activities on a consulting basis.

The executive management team of the company now consists of Leena Lakdawala, chief executive officer, and William Waks, chief financial officer. The new appointments are effective immediately, but remain subject to satisfactory review and approval by the TSX Venture Exchange.

The company further announces that an aggregate of 1.55 million incentive stock options have been granted to certain senior officers and directors of the company pursuant to the terms of the company's incentive stock option plan. The options are exercisable to acquire common shares of the company for a period of 10 years from the date of grant at a price of 15 cents per share. The foregoing options vest in equal tranches over a period of 18 months.

We seek Safe Harbor.